NKTR
Companies
NASDAQ
Nektar Therapeutics
Health Care
$8.61
-$5.45 (-39.07%)
Price Chart
Overview
About NKTR
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
Market Cap
$231.9M
Volume
25.7M
Avg. Volume
16.7M
P/E Ratio
-0.63935065
Dividend Yield
0.00%
Employees
478.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.65
High Correlation
Volatility
High (0.89)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, NKTR shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$231.9M
Volume25.7M
P/E Ratio-0.64
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 13, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025